FLT3 and acute myeloid leukemia: 7 abnormalities exhibit high expression of GPR56 and CD34. On the other hand, AML with FLT3-ITD with or without an NPM1 mutation and AML with DNMT3A mutation show high GPR56 and low CD34 expression.